Skip to main content
Log in

Influence of route of administration on therapeutic ratio of atropine in sham-fed dogs

  • Published:
The American Journal of Digestive Diseases Aims and scope Submit manuscript

Summary

Salivary and gastric secretory inhibition were studied simultaneously in 3 sham-fed dogs using atropine by 3 methods of administration.

The relationship of salivary inhibition to gastric inhibition was not parallel, varying with the method of administration.

It is concluded that continuous intravenous infusion of atropine may be an effective method of inhibiting gastric secretion without inhibiting salivary secretion.

The possible significance of this study for peptic ulcer research is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sun, D. C. H. Long-term anticholinergic therapy for prevention of recurrences in duodenal ulcer.Amer J Dig Dis 9:706, 1964.

    Google Scholar 

  2. Kubin, R. H., Keeler, W. R., andKlotz, A. P. Nonparallel gastric and salivary gland inhibition produced by anticholinergic drugs in sham-fed dogs.Amer J Dig Dis 12:371, 1967.

    Google Scholar 

  3. Hollander, F., Penner, A., Saltzman, M., andGlickstein, J. Secretory studies in whole stomachs; the determination of phenol red in gastric contents.Amer J Dig Dis 7:199, 1940.

    Google Scholar 

  4. Ursillo, R. C, andClark, B. B. The action of atropine on the urinary bladder of the dog and on the isolated nerve-bladder strip preparation of the rabbit.J Pharmacol Exp Ther 118:338, 1956.

    Google Scholar 

  5. Mushin, W., Galloon, S., andLewis-Faning, E. Anti sialogogue and other effects of atropine mucate.Brit Med J 2:652, 1953

    Google Scholar 

  6. Berkowitz, D. The effect of a long acting preparation (spansule) of belladonna alkaloids on gastric secretion of patients with peptic ulcer.Gastroenterology 30: 608, 1956.

    Google Scholar 

  7. Johnston, I. D. A. “Reduction of Gastric Acid Secretion Without Operation.” InRecent Advances in Gastroenterology, Badenoch, J., and Brooke, B. N., Eds. Churchill, London, 1965, p. 112.

    Google Scholar 

  8. Tønnesen, M. The absorption and distribution of atropine in rats.Acta Pharmacol (Kobenhaven)4:367, 1948.

    Google Scholar 

  9. Evertsbusch, V., andGeiling, E. M. K. Studies with radioactive atropine. I. Distribution and excretion patterns in the mouse.Arch Int Pharmacodyn 105: 175, 1956.

    Google Scholar 

  10. Kalser, S. C., Wills, J. H., Gabourel, J. D., Gosselin, R. E., andEpes, C. E. Further studies of the excretion of atropine alpha C14.J Pharmacol Exp Ther 121:449, 1957.

    Google Scholar 

  11. Janowitz, H. D., andHollander, F. Effect of atropine on histamine-stimulated gastric secretion in the dog.Amer J Physiol 186:373, 1956.

    Google Scholar 

  12. Gillespie, I. E., andKay, A. W. Effect of medical and surgical vagotomy on the augmented histamine test in man.Brit Med J 1:1557, 1961.

    Google Scholar 

  13. McArthur, J., Tankel, H. I., andKay, A. W. A comparison between the effects of hexamethonium and atropine in combination and of vagotomy with gastrojejunostomy on human gastric secretion.Gut 1: 230, 1960.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by Grant T 1 AM-5213-07 from the U. S. Public Health Service and a grant from Eli Lilly and Company.

Fellow in Gastroenterology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kubin, R.H., Keeler, W.R. & Klotz, A.P. Influence of route of administration on therapeutic ratio of atropine in sham-fed dogs. Digest Dis Sci 12, 363–370 (1967). https://doi.org/10.1007/BF02241938

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02241938

Keywords

Navigation